Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Tirzepatide also known as "Zepbound" and "Mounjaro" is weekly injectable medication classified as a dual GIP and GLP-1 receptor agonist. Alongside diet and exercise, it is used to improve blood sugar control in Type 2 diabetes, treat chronic weight management, and manage obstructive sleep apnea. Tirzepatide mimics two natural gut hormones (incretins) that stimulate insulin secretion, reduce the liver's production of sugar, slow stomach emptying, and signal to the brain that you are full. Because of these mechanisms, it leads to significant weight loss and glycemic control.
Tirzepatide also known as "Zepbound" and "Mounjaro" is weekly injectable medication classified as a dual GIP and GLP-1 receptor agonist. Alongside diet and exercise, it is used to improve blood sugar control in Type 2 diabetes, treat chronic weight management, and manage obstructive sleep apnea. Tirzepatide mimics two natural gut hormones (incretins) that stimulate insulin secretion, reduce the liver's production of sugar, slow stomach emptying, and signal to the brain that you are full. Because of these mechanisms, it leads to significant weight loss and glycemic control.